mynth
← DATABASE
07/2012100%

LVL Medical Germany acquired by Management & Private Investors

GERMANY Health Providers / Outpatient Care EV €50–150M

Context

Concomitantly with the Air Liquide acquisition of LVL Médical's French activities, the Lavorel family agreed to acquire 100% of LVL Médical Allemagne from LVL Médical Groupe. The transaction was structured as a mandatory prerequisite to the Air Liquide deal, as the latter's acquisition perimeter was explicitly limited to the French operations. The carve-out ensures a clean separation between the French and German businesses, with Air Liquide retaining full focus on the French home healthcare market and the Lavorel family continuing to develop the German operations autonomously. The transaction was agreed upon on a concurrent basis with the broader LVL Médical deal, with both closings expected in Q3 2012.

LVL Medical Germany, which reported an EBITDA margin of [members only] in 2009, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, to compare with the average currently observed in the Healthcare & Pharma sector (14.3x in 2026).

-> Deep-dive in Healthcare & Pharma market trends

Target

LVL Medical Allemagne is the German subsidiary of LVL Médical Groupe SA, a French home healthcare services group. Operating on the same model as its French parent, the German entity provides home-based medical services and equipment to patients suffering from chronic conditions, developing an intensive care delivery model structured around small local units combining strong field presence, patient proximity, and high-level technical services.

Ent. Value

€50–150M

Equity Value

[members only]

Multiples

EV / Revenue

1x–3x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2009
€50–100M
€5–25M
[members only]
2008
€50–100M
€5–25M
[members only]

Other operations with Management & Private Investors

Other operations with Management & Private Investors
DateAcquirerTargetCountrySector
10/2026MANAGEMENT & PRIVATE INVESTORSLAPEYREFRANCEBuilding & Interior Materials
09/2026MANAGEMENT & PRIVATE INVESTORSIRISH CONTINENTAL GROUP ICGIRELANDMarine Passenger
06/2026MANAGEMENT & PRIVATE INVESTORSJJAFRANCEHome & DIY
03/2026MANAGEMENT & PRIVATE INVESTORSMASA GROUPFRANCEDefense & Aerospace
03/2026MANAGEMENT & PRIVATE INVESTORSRIVALIS-HENRRIFRANCEERP, HR & Finance
02/2026MANAGEMENT & PRIVATE INVESTORSPRIMAL GROUP (FORMERLY SOLEM)FRANCEIoT & Connected Objects
01/2026MANAGEMENT & PRIVATE INVESTORSNOVARCFRANCEComponents
11/2025MANAGEMENT & PRIVATE INVESTORSPOGGIPOLINIITALYComponents
12/2023MANAGEMENT & PRIVATE INVESTORSATELIERS DE FRANCE (FORMERLY MERIGUET-CARRERE)FRANCEFinishing Works
08/2018MANAGEMENT & PRIVATE INVESTORSDESIGUALSPAINFashion & Apparel

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
01/2015CERBA HEALTHCARENOVESCIAFRANCELabs (Biology)
10/2014WATERLANDMEDIAN KLINIKENGERMANYClinics / Hospitals
09/2014EURAZEOCOLISÉEFRANCENursing Homes
06/2014PAI PARTNERSDOMUSVIFRANCENursing Homes
03/2014EQT PARTNERSI-MED RADIOLOGY NETWORKAUSTRALIARadiology
06/2012AIR LIQUIDEORKYN (EX LVL MEDICAL)FRANCEOutpatient Care
12/2010SAGA GROUPNESTOR HEALTHCARE GROUPUNITED KINGDOMOutpatient Care
06/2010PAI PARTNERSCERBA HEALTHCAREFRANCELabs (Biology)
05/2010HG CAPITALFRÖSUNDASWEDENHealthcare Facilities
03/2010BRIDGEPOINTCARE UKUNITED KINGDOMNursing Homes

REFERENCES

Valuation range: EV €50–150M

Revenue range: €50–100M

EBITDA range: €5–25M

EV/Revenue range: 1x - 3x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of LVL Medical Germany by Management & Private Investors are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers Management & Private Investors’s acquisition of 100% of LVL Medical Germany, a German company specialised in Outpatient Care, in 2012.

How was the acquisition of LVL Medical Germany by Management & Private Investors valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €50–150M band, its EV/EBITDA multiple within the 10x - 18x range, and its EV/revenue multiple within the 1x - 3x range. Exact figures are available to members.

What were LVL Medical Germany’s revenue and EBITDA at the time of the deal?

At the time of the transaction, LVL Medical Germany generated annual revenue estimated in the €50–100M range and EBITDA in the €5–25M bracket (FY 2009). Detailed financial figures are available to members.

How does the valuation of LVL Medical Germany compare to benchmarks in the Healthcare & Pharma sector?

With an estimated valuation multiple in the range of 10x - 18x in 2012, the transaction reflects historical valuation standards. By way of comparison, in 2026 companies in the Healthcare & Pharma sector are valued at a multiple of 14.3x EBITDA.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.